Authors: Sanchez, JF Hoh, F Strub, MP Strub, JM Van Dorsselaer, A Lehrer, R Ganz, T Chavanieu, A Calas, B Dumas, C Aumelas, A

Citation: Jf. Sanchez et al., Expression, purification, crystallization and preliminary X-ray analysis of the cathelicidin motif of the protegrin-3 precursor, ACT CRYST D, 57, 2001, pp. 1677-1679

Authors: Rousselle, C Smirnova, M Clair, P Lefauconnier, JM Chavanieu, A Calas, B Scherrmann, JM Temsamani, J

Citation: C. Rousselle et al., Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: Saturation kinetics and specificity, J PHARM EXP, 296(1), 2001, pp. 124-131

Authors: Yang, YS Mitta, G Chavanieu, A Calas, B Sanchez, JF Roch, P Aumelas, A

Citation: Ys. Yang et al., Solution structure and activity of the synthetic four-disulfide bond Mediterranean mussel defensin (MGD-1), BIOCHEM, 39(47), 2000, pp. 14436-14447

Authors: Schmitt-Bernard, CF Chavanieu, A Derancourt, J Arnaud, B Demaille, JG Calas, B Argiles, A

Citation: Cf. Schmitt-bernard et al., In vitro creation of amyloid fibrils from native and Arg124Cys mutated beta IGH3((110-131)) peptides, and its relevance for lattice corneal amyloid dystrophy type I, BIOC BIOP R, 273(2), 2000, pp. 649-653

Authors: Malliavin, TE Desvaux, H Aumelas, A Chavanieu, A Delsuc, MA

Citation: Te. Malliavin et al., Quantitative measurement of longitudinal and transverse cross-relaxation rates: An application to the analysis of the internal dynamics of ranalexin in water and trifluoroethanol, J MAGN RES, 140(1), 1999, pp. 189-199